The intestinal microbiota as a therapeutic target in the treatment of NAFLD and ALD

Abstract

Introduction: Liver diseases are currently common disorders worldwide. Especially, the proportion of patients with nonalcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD) is growing globally. An increasing number of studies have revealed a close relationship between the intestinal microbiota and the development of NAFLD and ALD. A better understanding of the role of intestinal microbiota and the intestine-liver axis thus might lead to the development novel therapies for the treatment of these diseases.

Keywords

• Nonalcoholic fatty liver disease
• Alcoholic liver disease
• Intestinal microbiota
• Intervention